Skip to main content
. 2017 Dec 20;12(12):e0189495. doi: 10.1371/journal.pone.0189495

Fig 1. Temporal trends of antithrombotic therapy prescription.

Fig 1

A. Temporal trends of antithrombotic therapy prescription in patients with CHA2DS2-VASc score ≥ 2. B. Distribution of three NOACs use since 2013 in patients with CHA2DS2-VASc score ≥ 2. Abbreviation: ASA, aspirin; NOAC, non-vitamin K oral anticoagulants; VKA, vitamin K antagonists.